Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose- A Double-blind, Placebo-controlled Clinical Research

NCT05737342 is registered in ClinicalTrials.gov with SunWay Biotech Co., LTD. as lead sponsor.

NCT NCT05737342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05737342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose- A Double-blind, Placebo-controlled Clinical Research
Lead sponsor
SunWay Biotech Co., LTD.
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2023
Completion date
October 31, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high blood sugar, metabolic syndrome